Introduction
Levetiracetam (LEV; [(S)-a-ethyl-2-oxo-1-pyrrolidine acetamide]) is a second generation anti-epileptic drug (AED) that is widely used in patients with either generalized or partial epileptic disorders. 1 LEV also has anti-ictogenic effects in animal models of epilepsy such as in the amygdala kindling model, 2 audiogenic kindling, 3 spontaneously epileptic rats 4 and the kainic acid model. 5 Unlike several other AEDs, 6 LEV does not block voltage-dependent Na + but may decrease glutamatergic excitatory transmission, 7 thus preventing excessive neuronal synchronization. 8 Although the exact mechanisms through which LEV controls seizures remain unclear, its anticonvulsive properties are thought to rely on its ability to modulate neurotransmission by binding to SV2A, a synaptic vesicle glycoprotein that interacts with synaptotagmin, a pre-synaptic Ca 2+ sensor involved in regulating synaptic vesicle exocytosis. 9 MTLE is the most prevalent type of partial epileptic disorders, with symptoms consisting of partial seizures that originate from the hippocampus, entorhinal cortex or amygdala many years after an initial brain insult such as status epilepticus (SE), encephalitis or febrile convulsions. 10 MTLE is also one of the most refractory forms of epilepsy with approximately one third of patients being unresponsive to medication. 11 In these patients, the surgical removal of the seizure onset zone often represents the only therapeutic alternative, which may sometimes necessitate the use of invasive intracranial EEG recordings to properly delineate the seizure onset zone.
networks, since the surgical removal of regions with HFOs is associated to good post-surgical outcomes. [14] [15] [16] [17] [18] Animal studies have also shown that HFOs may be linked to epileptogenesis and ictogenesis. 8, 19, 20 The relation between seizures, interictal spikes, HFOs and the effect of anti-epileptic drugs is however still unclear. A study performed in epileptic patients has shown that HFOs may increase after medication reduction. 21 However, these studies were carried out in patients with ''well-established'' epileptic conditions, and were limited by the variability of AEDs. We analyzed here the effects of LEV on seizures, interictal spikes and HFOs in the pilocarpine model of MTLE, and focused on the 4-14 day period that follows the initial pilocarpine-induced SE.
Methods

Ethical approval
All procedures were approved by the Canadian Council of Animal Care and all efforts were made to minimize the number of animals and their suffering.
Animal preparation
Male Sprague-Dawley rats (250-300 g) were obtained from Charles River (St-Constant, Qc, Canada) and let habituate for 72 h after delivery before pilocarpine treatment. They were housed in controlled conditions, at 22 (AE2) 8C and under a 12 h light/12 h dark cycle (lights on from 7:00 AM to 7:00 PM) with food and water ad libitum.
Pilocarpine treatment
Animals were injected with scopolamine methylnitrate (1 mg/ kg i.p.; Sigma-Aldrich, Canada) and 30 min later with a single dose of pilocarpine hydrochloride (380 mg/kg, i.p.; Sigma-Aldrich, Canada). 8 Their behaviour was scored according to the Racine scale 22 and SE was defined as continuous stage 5 seizures. Status epilepticus (SE) was terminated after 1 h by an injection of diazepam (5 mg/kg, s.c.; CDMV, Canada) and ketamine (50 mg/ kg, s.c.; CDMV, Canada). 8 
Treatment with levetiracetam
Approximately 4 h after SE termination, seven animals were anesthetized with isoflurane (2%) in 100% O 2 and an osmotic pump (2 ml, flow rate: 5 ml/h) was installed subcutaneously (2ML2 ALZET osmotic mini-pumps, DURECT Corporation, Cupertino, CA, USA) in order to deliver LEV dissolved in saline at 300 mg/kg/day. 23 These pumps deliver a continuous dosing over 2 weeks, circumventing the need for repetitive invasive blood sampling. Osmotic pumps filled with saline were installed subcutaneously in controls.
Surgery for the implantation of electrodes
All animals underwent surgery for the implantation of electrodes three days after pilocarpine treatment. Before surgery, animals received topical Lidocain (5%; Odan, Canada). An incision was then made in the skin to expose the skull plate, from bregma to lambda. Four stainless steel screws (2.4 mm length) were fixed to the skull and four small holes were drilled to allow the implantation of bipolar electrodes (20-30 kV; 5-10 mm length; distance between exposed tips: 500 mm) (MS303/2-B/spc, Plastics One, VA, USA). Electrodes were implanted in the CA3 subfield of the ventral hippocampus (AP: À4.4, ML: 4, DV: 7.8), medial entorhinal cortex (AP: À8.6, ML: 5.2, DV: 6.8), ventral subiculum (AP: À6.8, ML: 4, DV: 6) and dentate gyrus (AP: À4.4, ML: 2.4, DV: 3.4). Recordings were performed in the right CA3 and EC and in the left DG and subiculum. Screws and electrode pins were connected with a pin connector and fastened to the skull with dental cement. A fifth bipolar electrode was placed under the frontal bone, after the removal of insulating material, and used as reference. During surgery, animals received a preventive antibio-therapy (Enrofloxacine, 10 mg/kg, s.c.). After surgery, animals were injected with Ketoprofen (5 mg/kg, s.c. Merail, Canada), Buprenorphine (0.01-0.05 mg/kg, s.c., CDMV, Canada) and 2 ml of 0.9% sterile saline (s.c.).
EEG recordings
The pin connector was connected to a multichannel cable and electrical swivel (Slip ring T13EEG, Air Precision, France; or Commutator SL 18C, HRS Scientific, Canada) and EEG-video monitoring (24 h/day) was performed. EEGs were amplified via an interface kit (Mobile 36ch LTM ProAmp, Stellate, Montreal, QC, Canada), low-pass filtered at 500 Hz and sampled at 2 kHz per channel. Infrared cameras were used to record day/night video files that were time-stamped for integration with the electrophysiological data using monitoring software (Harmonie, Stellate, Montreal, QC, Canada). Continuous 24/7 EEG-video recordings were performed from day 4 to day 14 after SE.
Spontaneous seizures and onset patterns
All EEG and video recordings were reviewed manually in order to detect seizures. The time corresponding to the onset and end of each seizure was recorded and the behaviour of the animal was graded on the Racine scale. 22 Seizures were also classified in two groups according to their onset pattern. Low-voltage fast-onset seizures (LVF) were characterized by the occurrence of a positiveor negative-going spike that was followed by the appearance of low amplitude high frequency activity. Hypersynchronous-onset seizures (HYP) were characterized at onset by a pattern of focal periodic spiking at a frequency of approximately 2 Hz. Seizures for which a seizure onset pattern could not be identified were named ''unclassified''. The duration of seizures was based on the first occurrence of activity in the 5-20 Hz range until the return to baseline activity and normal behaviour. The duration of seizures was calculated from the onset of activity in the 5-20 Hz range (see arrows in Figs. 2 and 3) until the return to baseline EEG activity. The occurrence of a spontaneous seizure (non-convulsive or convulsive) after SE marked the end of the latent period. Based on the presence or absence of spontaneous seizures between the 4th and the 14th day after SE, LEV-treated animals were divided in two groups, those with seizures (LEV w Sz) and those without seizures (LEV w/o Sz).
Analysis of interictal spikes and high-frequency oscillations
To reduce the potential variability in interictal spike occurrence due to seizures in the LEV-treated group, we excluded LEV w Sz animals from the analysis of interictal spikes and HFOs. For each control and LEV w/o Sz animal, two epochs of 10 min were selected for each day in order to analyze interictal spikes and HFOs. In order to reduce a possible bias on seizures and interictal activities caused by the light/dark cycle, we selected from each recording day one epoch during the light period (from 7 AM to 7 PM) and a second epoch during the dark period (from 7 PM to 7 AM). Only epochs of non-REM sleep were used for analysis, because of the low rate of movement artefacts and because HFOs are more prominent during this sleep stage. 24 Non-REM sleep epochs were selected based on the occurrence of EEG activity in the 1-6 Hz range. In order to minimize the effects of seizure occurrence during the chronic phase, epochs were selected at least 1 h before or after seizures. Interictal spikes were detected based on threshold crossings (mean and standard deviation (SD)), calculated over the entire period for the 10-min epoch. Events above 4 SD were considered as interictal spikes and movement artefacts were removed from the analysis. The rate of interictal spikes (number of events/s) was then calculated for each region (CA3, EC, DG and subiculum) and results obtained from the two epochs (dark and light period) were averaged in order to obtain a single value per day per animal.
The same epochs used to detect interictal spikes were used for the analysis of HFOs. The algorithm used to detect these events was previously published 25 and will be briefly described here. The algorithm identified oscillations in each frequency range (ripples: 80-200 Hz, fast ripples: 250-500 Hz), using routines based on standardized functions (Matlab Signal Processing Toolbox, Matlab R2013a (Mathworks)). Raw EEG recordings were first bandpass filtered in the 80-200 Hz and in the 250-500 Hz frequency range. Filtered EEGs from each region were then normalized using their own average root mean square value calculated over the 10-min epoch. To be considered as an HFO candidate, oscillatory events in each frequency band had to show at least four consecutive cycles having amplitude of 3 SD above the mean. HFOs were considered as co-occurring with a spike if they occurred within a time window of AE300 ms from the peak of an interictal spike. Ripples were kept for analysis only if they were detected in the 80-200 Hz range, whereas fast ripples were kept if they were detected only in the 250-500 Hz range. Rates of HFOs were calculated for each day by averaging values obtained from the light and dark time-period.
Statistical analysis
Results are expressed as mean (AEstandard error of mean (SEM)). Statistical analyses were performed in Matlab R2013a. Nonparametric Kruskal-Wallis and Wilcoxon signed-rank tests were used to compare values obtained in each group, since values were not normally distributed according to the Kolmogorov-Smirnov test. Fisher's exact tests were also used for the analysis of percentages in contingency tables. The level of significance was set at p < 0.05.
Results
Seizure occurrence and latent period
Seizures were recorded in both controls and LEV-treated animals. However, all controls (n = 12) showed seizures (n = 339 seizures) compared to only 29% (2/7) of LEV-treated animals (n = 32 seizures), after a latent period of similar duration (Fig. 1A) . In both groups, seizures tended to occur in clusters, with a first cluster between day 6 and day 11 after SE (Fig. 1B) . However, when analysing seizure rates from day 4 to day 14 after SE, they were significantly lower in the LEV w Sz group compared to the control group (control = 2.8 (AE0.4) seizures per day, LEV w Sz = 1.5 (AE0.5), p < 0.05). When comparing the proportions of convulsive and nonconvulsive seizures in each group, LEV w Sz animals were more likely to show non-convulsive seizures compared to controls (p < 0.05, Fisher's exact test) (Fig. 1C) . Finally, the duration of seizures was not significantly different between the two groups (Fig. 1D) .
Seizure onset patterns
HYP and LVF seizures were observed in both groups ( Fig. 2A-D) . In control animals, HYP seizures occurred more frequently compared to LVF seizures and unclassified seizures (Fig. 2E) . A similar distribution of seizure onset patterns was observed in the LEV w Sz group (Fig. 2F ).
Interictal spikes
We compared LEV w/o Sz animals (n = 4) to control animals (n = 4) in order to know if the anti-ictogenic effect of LEV was mirrored by differences in interictal spike and HFO occurrence. A total of 15 h of interictal activity was analyzed for each group (two 10-min epochs in each animal from every day of recording between day 4 and day 14 after SE). This analysis was performed over 30,500 interictal spikes in the control group and 19,606 interictal spikes in the LEV-treated group.
Interictal spikes were recorded in all controls and LEV w/o Sz animals and could occur in any region of the temporal lobe (Fig. 3A  and B) . Analysis of interictal spike rates revealed that in all regions, LEV w/o Sz animals had significantly lower values than in controls (p < 0.05 and p < 0.01) (Fig. 3C ). Fig. 3D shows the evolution of interictal spike rates over time. In CA3 and subiculum, the low rates of interictal spikes in LEV w/o Sz animals were maintained over time.
Ripples (80-200 Hz)
As previously reported in epileptic patients and animal models, 19, 26, 27 interictal spikes could co-occur with HFOs. All controls and all LEV w/o Sz animals showed interictal spikes with ripples ( Fig. 4A) , on every day of recording after SE. However, in LEV w/o Sz animals, interictal spikes with ripples occurred at significantly lower rates compared to controls. This difference reached significance in CA3, EC and subiculum (p < 0.01) (Fig. 4B) . Fig . 4C shows rates of interictal spikes with ripples over time. From day 4 to day 14 after SE, LEV w/o Sz animals showed lower rates of interictal spikes with ripples compared to controls in CA3, EC and subiculum.
Fast ripples (250-500 Hz)
Interictal spikes with fast ripples were recorded from controls and LEV w/o Sz animals as well (Fig. 5A) . As for ripples, interictal spikes with fast ripples occurred at significantly lower rates in LEV w/o Sz animals compared to controls, and this difference reached significance in CA3 and subiculum (p < 0.01) (Fig. 5B) . Fig. 5C shows the average occurrence over time of interictal spikes with fast ripples in both groups. As it was observed for ripples, the low rates of interictal spikes with fast ripples in LEV w/o Sz animals were maintained over time.
Next, we wanted to confirm the hypothesis that interictal spikes with fast ripples in CA3 were the best predictor of seizure occurrence, as previously reported by Lé vesque et al. 19 We thus performed a linear regression analysis between rates of seizures and rates of interictal spikes with fast ripples in all regions. As previously shown, 19 interictal spikes with fast ripples in CA3 were the best predictors of seizure occurrence in controls (p < 0.05) (Fig. 5D ). This relation was not observed in LEV w Sz animals. 
Discussion
The main findings of our study can be summarized as follows. First, from the 4th to the 14th day after a pilocarpine-induced SE, only 29% of LEV-treated animals showed seizures compared to all controls, after latent periods of similar durations. Second, LEV w Sz animals were more likely to have non-convulsive seizures compared to controls. Third, interictal spikes occurred in all regions, but at lower rates in LEV w/o Sz animals compared to controls. Fourth, LEV w/o Sz animals showed significantly lower rates of occurrence of interictal spikes with ripples in CA3, EC and subiculum, whereas rates of interictal spikes with fast ripples were significantly lower in CA3 and subiculum, compared to controls. Finally, in controls but not in LEV w Sz animals, rates of interictal spikes with fast ripples in CA3 predicted seizure occurrence.
Effects of levetiracetam on seizures
We have found that LEV has effective anti-ictogenic properties in the pilocarpine model of MTLE. This is in line with previous in vivo studies using either pilocarpine 28 or kainic acid 5 and it is consistent with the seizure-suppressing effect of LEV observed in epileptic patients. 29 We cannot however exclude the fact that LEV w/o Sz animals may also develop seizures after 14 days post-SE, indicating that LEV may only delay the occurrence of the first spontaneous seizure. Future studies should be performed with long-term recordings under LEV since our study mainly focused on the early chronic period. We have also found that the severity of seizures in LEV w Sz animals was significantly lower compared to controls. This is in line with what was reported by Van Vliet et al, 30 who discovered that following an electrically induced SE, the severity of spontaneous seizures was reduced by LEV treatment. In addition, Zheng et al 31 have found an attenuation of behavioural symptoms when LEV was administered intravenously 30 min after the onset of pilocarpine-induced acute seizures. The mechanisms through which LEV decreases the behavioural counterpart of seizures remain undefined but it has been proposed that it depends on the ability of LEV to reduce neuronal synchronization between the hippocampus and cortex. 32 We have observed however that seizures had similar durations in the control and in the LEV w Sz group. Few studies have investigated the effect of LEV on the duration of spontaneous seizures and only contradictory results were obtained so far. For instance, no effect of LEV was observed on seizure duration in the pilocarpine model 28 or following an electrically induced SE. 30 However, a decrease in duration was shown in the kainic acid model 5 and in the tetanus toxin model. 33 These discrepancies could be due to multiple factors associated to the methods used to induce SE (e.g., electrical stimulation or chemoconvulsant treatments). Also, in these studies, different doses of LEV as well as different modalities of administration (i.e., systemic or intraventricular) were used. These methodological discrepancies could explain, at least in part, the different effects induced by LEV on the duration of seizures reported to date.
Effects of levetiracetam on interictal spikes and high-frequency oscillations
We have found that compared to the control group, LEV w/o Sz animals had significantly lower rates of interictal spikes in all recorded regions. This is in line with clinical studies, since a similar effect of LEV on interictal spikes was observed in patients with partial seizures. 34 Furthermore, we found that LEV induced lower rates of occurrence of interictal spikes with ripples or fast ripples compared to controls. To our knowledge, this is the first study showing the effect of an AED on HFOs in an animal model of MTLE, and it is in line with studies performed in epileptic patients showing that ripples and fast ripples are sensitive to AEDs. 21 Specifically, our results suggest that network activity in specific limbic regions such as CA3, EC and subiculum is affected by the administration of this AED. It has been proposed that ripples represent population IPSPs generated by principal neurons entrained by synchronously active interneuron networks whereas fast ripples are thought to reflect the hypersynchronous firing of principal (glutamatergic) neurons. 13 Fast ripples are considered as better predictors of seizure occurrence and of seizure onset zones compared to ripples. 13 However, the fact that LEV modulates both fast ripples and ripples suggest that a particular subgroup of ripples could be pathological and highly sensitive to AEDs. In epileptic patients implanted with depth electrodes, ripples can occur in the hippocampus and entorhinal cortex, on either side of the brain, independently of the side of seizure onset. 35 These results thus suggest that ripples occurring on interictal spikes could reflect the activity of neuronal networks that are not necessarily located in the seizure onset zone, but that are nonetheless dysfunctional in the epileptic brain. In our study, the decrease of fast ripple activity occurred in temporal lobe regions that are known to play important roles in MTLE, namely CA3 and subiculum. The CA3 region of the hippocampus is highly sensitive to neuronal damage induced by the initial SE, 36 is one of the first region to show epileptiform activity during the latent period 37 and is often the onset zone of spontaneous seizures. 8, 19, 38 Furthermore, we previously proposed that the occurrence of interictal spikes with fast ripples in CA3 may mirror the evolutionary state of the epileptogenic tissue and reveal pathologic activity from regions that will bring neural networks close to seizure onset. 19 The results reported here support this hypothesis since we found a significant correlation in CA3 between rates of interictal spikes with fast ripples and seizure rates in controls. The anti-ictogenic properties of LEV could thus be due to its ability to inhibit excessive synchronization in CA3 32 that would be reflected by a decrease in fast ripple occurrence. Finally, a decrease of fast ripple occurrence in the subiculum of LEV w/o Sz animals may mirror an inhibiting effect of this AED on pathological neuronal excitability associated to MTLE, as suggested by experiments performed in the resected human tissue. 39, 40 Spontaneous rhythmic spikes similar to interictal spikes recorded in vivo can propagate from the subiculum to the hippocampus in the tissue of patients with MTLE 39 and glutamatergic pre-ictal discharges in the subiculum induced by low levels Mg 2+ can trigger seizures. 40 In vitro, reduced GABAergic inhibition and a corresponding increase in subicular excitability were found in pilocarpinetreated animals. 41 This increased excitability may lead to spontaneous rhythmic activity, polysynaptic response and all-or-none bursts of action potentials in these animals. 42 Thus, since LEV w/o Sz animals showed low rates of interictal spikes with HFOs in the subiculum, pathological network activity in this region may play an important role in the transition from interictal activity to ictal activity in MTLE and represent an important therapeutic target. Further studies are however needed in order to investigate if this decrease in HFO occurrence reflects a disease-modifying property of LEV. It should be emphasized that previous studies have proposed that LEV may have antiepileptogenic properties since its anti-ictogenic effect can persist for many days after treatment cessation in spontaneously epileptic rats, 4 in kainic-acid treated 5 and in amygdala-kindled rats. 2 
Conclusion
LEV has potent anti-ictogenic properties in the pilocarpine model of MTLE that is mirrored by a decrease in the occurrence of interictal spikes and HFOs, considered to be biomarkers of abnormal network activity. Our results thus further illustrate the potential of this AED in the treatment of MTLE and possibly its ability to induce pharmacological changes that will inhibit neural networks reorganization leading to the occurrence of spontaneous seizures.
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